HEALTHIA LIMITED (HLA)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
HLA - HEALTHIA LIMITED
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 4.41
Index: ALL-ORDS
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$1.795
30 Nov |
OPEN $1.80 |
HIGH $1.80 |
135,433 LOW $1.80 |
0.003| OTHER COMPANIES IN THE SAME SECTOR | |||
| ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
Last ex-div: 08/09 - ex-div 2c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | 4.0 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 252.6 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 109.2 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 22.6 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 2.16 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 3.78 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 1.96 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | 1.45 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | 3.78 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 8.13 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 12.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 21 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 146 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 167 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 257 M |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 6 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 0.92 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 7.6 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 2.99 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 202 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 23 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
HLA STOCK CHART
FNArena News on HLA
Latest Healthcare services News
| 1 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
| 2 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
| 3 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
| 4 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
| 5 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
| 6 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
| 7 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
| 8 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |
| 9 |
Ramsay Stakes Future on Mental HealthDec 20 2021 - Australia |
| 10 |
Ramsay Health Care: Finally A Break-OutNov 09 2021 - Technicals |
